Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.
N Ferrara, … , G A Keller, A D Levinson
N Ferrara, … , G A Keller, A D Levinson
Published January 1, 1993
Citation Information: J Clin Invest. 1993;91(1):160-170. https://doi.org/10.1172/JCI116166.
View: Text | PDF
Research Article Article has an altmetric score of 6

Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.

  • Text
  • PDF
Abstract

Vascular endothelial growth factor (VEGF) is a mitogen with a specificity for endothelial cells in vitro and an angiogenic inducer in vivo. We tested the hypothesis that VEGF may confer on expressing cells a growth advantage in vivo. Dihydrofolatereductase--Chinese hamster ovary cells were transfected with expression vectors which direct the constitutive synthesis of VEGF. Neither the expression nor the exogenous administration of VEGF stimulated anchorage-dependent or anchorage-independent growth of Chinese hamster ovary cells in vitro. However, VEGF-expressing clones, unlike control cells, demonstrated an ability to proliferate in nude mice. Histologic examination revealed that the proliferative lesions were compact, well vascularized, and nonedematous. Ultrastructural analysis revealed that capillaries within the lesions were of the continuous type. These findings indicate that the expression of VEGF may confer on cells the ability to grow in vivo in the absence of transformation by purely paracrine mechanisms. Since VEGF is a widely distributed protein, this property may have relevance for a variety of physiological and pathological proliferative processes.

Authors

N Ferrara, J Winer, T Burton, A Rowland, M Siegel, H S Phillips, T Terrell, G A Keller, A D Levinson

×

Total citations by year

Year: 2022 2021 2020 2019 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 Total
Citations: 1 1 1 1 1 3 1 1 2 4 1 3 5 1 4 3 3 5 8 7 14 8 12 13 11 9 3 126
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (126)

Title and authors Publication Year
Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression.
Sterling C Jr, Márquez-Garbán D, Vadgama JV, Pietras RJ
Cancers 2022
Modulation of C5a-C5aR interactions against murine mammary cancer cell line
KN H., BN F., MH Noor
Comparative Clinical Pathology 2021
Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
SK Kohli, A Bhardwaj, V Bhardwaj, A Sharma, N Kalia, M Landi, R Bhardwaj
Biomolecules 2020
Vascular patterns in basal cell carcinoma: Dermoscopic, confocal and histopathological perspectives (Review)
M Lupu, C Caruntu, M Popa, V Voiculescu, S Zurac, D Boda
Oncology Letters 2019
Expression of hypoxia inducible factors and vascular endothelial growth factor during pregnancy in the feline uterus
ÖK Ağaoğlu, AR Ağaoğlu, A Güzeloğlu, E Kurar, SA Kayiş, Ö Özmen, S Schäfer-Somi, S Aslan
Theriogenology 2015
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Outstanding Marine Molecules
ML Bourguet-Kondracki, JM Brunel
Outstanding Marine Molecules 2014
Fluorescent labeling for clonal selection of Marc 145 cells secreting high levels of recombinant protein PBD-1
HJ Huang, X Peng, B Deng, C Huang, J Li, YG Qian, QS Gao, M Xiang, S Lu, ZH Chen, CY Zhan, L Zhou, BF Tao, J Liu, BZ Tan
Cytotechnology 2014
GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction
SM Huang, TS Chen, CM Chiu, LK Chang, KF Liao, HM Tan, WL Yeh, GR Chang, MY Wang, DY Lu
Endocrine Related Cancer 2013
Effect of process parameters and product-host-interaction on hVEGFA-production by recombinant Chinese hamster ovary cells
D Freimark, V Jérôme, R Freitag
Biotechnology Progress 2012
Gynecologic Oncology
A Vasilev, S Vasilev
Gynecologic Oncology 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke
J Shimotake, N Derugin, M Wendland, ZS Vexler, DM Ferriero
Stroke; a journal of cerebral circulation 2010
Angiogenesis
TH Adair, JP Montani
Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2010
A GFP-based method facilitates clonal selection of transfected CHO cells
D Freimark, Và Jèrôme, R Freitag
Biotechnology Journal 2010
Palm Tocotrienols Inhibit Proliferation of Murine Mammary Cancer Cells and Induce Expression of Interleukin-24 mRNA
KR Selvaduray, AK Radhakrishnan, MK Kutty, K Nesaretnam
Journal of Interferon & Cytokine Research 2010
Trial Design Strategies for Vascular-Targeted Therapy of Patients with Ovarian Cancer
MA Varughese, JA Ledermann
Clinical Ovarian Cancer 2009
Vascular determinants of cancer stem cell dormancy-do age and coagulation system play a role? 
J Rak, C Milsom, J Yu
APMIS 2008
Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice
MH Hassan, E Eyzaguirre, HM Arafa, FM Hamada, SA Salama, A Al-Hendy
American Journal of Obstetrics and Gynecology 2008
Antiangiogenic Agents in Cancer Therapy
BA Teicher, LM Ellis
2008
VEGF in physiological process and thyroid disease
M Klein, B Catargi
Annales d'Endocrinologie 2007
Le VEGF en physiologie et pathologie thyroïdienne
M Klein, B Catargi
Annales d'Endocrinologie 2007
Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice
M Bequet-Romero, M Ayala, BE Acevedo, EG Rodríguez, OL Ocejo, I Torrens, JV Gavilondo
Angiogenesis 2007
In-silico fragment-based identification of novel angiogenesis inhibitors
S Dakshanamurthy, M Kim, ML Brown, SW Byers
Bioorganic & Medicinal Chemistry Letters 2007
Spectrum of Activity and Mechanism of Action of VEGF/PDGF Inhibitors
J Homsi, AI Daud
Cancer control : journal of the Moffitt Cancer Center 2007
The safety of bevacizumab
RE Sanborn, AB Sandler
Expert Opinion on Drug Safety 2006
The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review
D Ribatti
British Journal of Haematology 2005
Antiangiogenic Steroids in Human Cancer Therapy
RJ Pietras, OK Weinberg
Evidence-based complementary and alternative medicine : eCAM 2005
Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF)
LA Strickland, AM Jubb, JA Hongo, F Zhong, J Burwick, L Fu, GD Frantz, H Koeppen
The Journal of Pathology 2005
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial
FF Kabbinavar, J Schulz, M McCleod, T Patel, JT Hamm, JR Hecht, R Mass, B Perrou, B Nelson, WF Novotny
Journal of Clinical Oncology 2005
Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours
AM Jubb, TQ Pham, AM Hanby, GD Frantz, FV Peale, TD Wu, HW Koeppen, KJ Hillan
Journal of clinical pathology 2004
Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma
M Uehara, K Sano, H Ikeda, J Sekine, A Irie, T Yokota, T Tobita, S Ohba, T Inokuchi
Oral Oncology 2004
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
DH Johnson, L Fehrenbacher, WF Novotny, RS Herbst, JJ Nemunaitis, DM Jablons, CJ Langer, RF DeVore, J Gaudreault, LA Damico, E Holmgren, F Kabbinavar
Journal of Clinical Oncology 2004
Interactions Between Estrogen and Growth Factor Receptors in Human Breast Cancers and the Tumor-Associated Vasculature
RJ Pietras
The Breast Journal 2003
Interferon-  Is Implicated in the Transcriptional Regulation of Vascular Endothelial Growth Factor
G Tosato
JNCI Journal of the National Cancer Institute 2003
The Relationship between Serum VEGF Concentration and Prognosis of Lung Cancer
SH Park, SS Lee
The Korean Journal of Internal Medicine 2003
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
G Fontanini, P Faviana, M Lucchi, L Boldrini, A Mussi, T Camacci, MA Mariani, CA Angeletti, F Basolo, R Pingitore
British Journal of Cancer 2002
VEGF and the quest for tumour angiogenesis factors
N Ferrara
Nature Reviews Cancer 2002
Distribution of VEGF mRNA in breast cancer with nonradioactive in situ hybridization at electron microscopic levels
Y Wang, YL Li, X Wang, Y Li, S Wu, L Zhang
Chinese Journal of Cancer Research 2002
Angiogenic and Lymphangiogenic Molecules in Hematological Malignancies
A Orpana, P Salven
Leukemia & Lymphoma 2002
Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression
D Li, JI Williams, RJ Pietras
Oncogene 2002
Transforming growth factor-? and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis
G Breier, S Blum, J Peli, M Groot, C Wild, W Risau, E Reichmann
International Journal of Cancer 2001
Vascular Endothelial Growth Factor/Vascular Permeability Factor in the Pathogenesis of Primary Effusion Lymphomas
Y Aoki, G Tosato
Leukemia & Lymphoma 2001
VEGF antagonists
GC Jayson, J Hasan
Expert Opinion on Biological Therapy 2001
Morphologic analysis of microvessels in colorectal tumors with respect to the formation of liver metastases
T Yamamura, S Tsukikawa, K Yamada, S Yamaguchi
Journal of Surgical Oncology 2001
Antiangiogenic agents and their promising potential in combined therapy
PA Burke, SJ DeNardo
Critical Reviews in Oncology/Hematology 2001
Les mécanismes de lˈangiogenèse. Applications médicales et thérapeutiques
T Couffinhal, P Dufourcq, D Daret, C Duplaà
La Revue de Médecine Interne 2001
Genetic Basis of the Barrett???s Metaplasia, Dysplasia, Adenocarcinoma Sequence:
RV N.
Problems in General Surgery 2001
Endotoxins induce and interferon‐α suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells
P Salven, K Anttonen, H Repo, H Joensuu, A Orpana
The FASEB Journal 2001
Expression of Vascular Endothelial Growth Factor Induces an Invasive Phenotype in Human Squamous Cell Carcinomas
M Detmar, P Velasco, L Richard, KP Claffey, M Streit, L Riccardi, M Skobe, LF Brown
The American Journal of Pathology 2000
Tumor Angiogenesis
M Detmar
Journal of Investigative Dermatology Symposium Proceedings 2000
Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study withSainte-Anne malignancy grade, growth fractionand patient survival
P Varlet, JS Guillamo, F Nataf, M Koziak, F Beuvon, C Daumas-Duport
Neuropathology and Applied Neurobiology 2000
The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer
W Tjalma
European Journal of Obstetrics & Gynecology and Reproductive Biology 2000
Assessing the Role of Gene Therapy in the Treatment of Vascular Disease
PL Faries, FB Pomposelli, WC Quist, FW LoGerfo
Annals of Vascular Surgery 2000
Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients
P Salven, A Orpana, L Teerenhovi, H Joensuu
Blood 2000
Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor
Z Zhu, L Witte
Investigational New Drugs 2000
Vascular Endothelial Growth Factor Expression as a Prognostic Index in Serous Ovarian Cystoadenocarcinomas: Relationship with MIB1 Immunostaining
GG Garzetti, A Ciavattini, G Lucarini, A Pugnaloni, MD Nictolis, S Amati, C Romanini, G Biagini
Gynecologic Oncology 1999
Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis
J Rak, Y Mitsuhashi, C Sheehan, JK Krestow, VA Florenes, J Filmus, RS Kerbel
Neoplasia (New York, N.Y.) 1999
Serum VEGF levels in women with a benign breast tumor or breast cancer
P Salven, V Perhoniemi, H Tykkä, H Mäenpää, H Joensuu
Breast Cancer Research and Treatment 1999
NEUTRALIZING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODY INHIBITS FURTHER GROWTH OF ESTABLISHED PROSTATE CANCER AND METASTASES IN A PRE-CLINICAL MODEL
O Melnyk, M Zimmerman, KJ Kim, M Shuman
The Journal of Urology 1999
Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression
MP Wong, N Cheung, ST Yuen, SY Leung, LP Chung
International Journal of Cancer 1999
Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma
N Wakisaka, QH Wen, T Yoshizaki, T Nishimura, M Furukawa, E Kawahara, I Nakanishi
The Laryngoscope 1999
Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression
M Aonuma, Y Saeki, T Akimoto, Y Nakayama, C Hattori, Y Yoshitake, K Nishikawa, M Shibuya, NG Tanaka
International Journal of Experimental Pathology 1999
Advances in Oncobiology
DL Miller, FG Kern
Advances in Oncobiology 1999
Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily
Y Zhai, J Yu, L Iruela-Arispe, WQ Huang, Z Wang, AJ Hayes, J Lu, G Jiang, L Rojas, ME Lippman, J Ni, GL Yu, LY Li
International Journal of Cancer 1999
Experimental small bowel transplantation using newborn intestine in rats: II. Revascularization of newborn intestine is independent of vascular endothelial growth factor
H Uchida, E Kobayashi, K Yanagisawa, K Mizuta, Y Kitoh, A Fujimura, S Tominaga, H Kawarasaki, K Hashizume
Journal of Pediatric Surgery 1999
Expression of vascular endothelial growth factor promotes colonization, vascularization, and growth of transplanted hepatic tissues in the mouse
I Ajioka, T Akaike, Y Watanabe
Hepatology 1999
Vascular Growth Factors and Angiogenesis
L Claesson-Welsh
1999
Angiogenesis and Hematopoiesis Induced by Kaposi’s Sarcoma-Associated Herpesvirus-Encoded Interleukin-6
Y Aoki, ES Jaffe, Y Chang, K Jones, J Teruya-Feldstein, PS Moore, G Tosato
Blood 1999
Role of Vascular Endothelial Growth Factor/Vascular Permeability Factor in the Pathogenesis of Kaposi's Sarcoma-Associated Herpesvirus-Infected Primary Effusion Lymphomas
Y Aoki, G Tosato
Blood 1999
Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
SI Ishigami, S Arii, M Furutani, M Niwano, T Harada, M Mizumoto, A Mori, H Onodera, M Imamura
British Journal of Cancer 1998
Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status
T Maeda, S Matsumura, H Hiranuma, A Jikko, S Furukawa, T Ishida, H Fuchihata
Journal of clinical pathology 1998
Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
P Salven, A Lymboussaki, P Heikkilä, H Jääskela-Saari, B Enholm, K Aase, G Euler, U Eriksson, K Alitalo, H Joensuu
The American Journal of Pathology 1998
The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis
G Barillari, L Albonici, O Franzese, A Modesti, F Liberati, P Barillari, B Ensoli, V Manzari, G Santeusanio
The American Journal of Pathology 1998
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
P Salven, T Ruotsalainen, K Mattson, H Joensuu
International Journal of Cancer 1998
Advances in Organ Biology
AJ Liedtke
Advances in Organ Biology 1998
Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis
CC Chen, FE Mo, LF Lau
Journal of the American Society of Nephrology : JASN 1998
Growth factor-mediated angiogenesis in the malignant progression of glial tumors: A review
RL Jensen
Surgical neurology 1998
Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies
S Takeshita, LP Zheng, E Brogi, M Kearney, LQ Pu, S Bunting, N Ferrara, JF Symes, JM Isner
Journal of Clinical Investigation 1997
Halting angiogenesis suppresses carcinoma cell invasion
M Skobe, P Rockwell, N Goldstein, S Vosseler, NE Fusenig
Nature Medicine 1997
Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase
J Marcoval, A Moreno, J Graells, A Vidal, JM Escriba, M Garcia-Ramirez, A Fabra
Journal of Cutaneous Pathology 1997
Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate samples of breast carcinoma: Fine-needle aspirates vs. resection samples
K Anan, T Morisaki, M Katano, A Ikubo, Y Tsukahara, A Uchiyama, S Kuroki, M Tanaka, M Torisu
Journal of Surgical Oncology 1997
Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: An immunohistochemical study
NH Chow, PI Hsu, XZ Lin, HB Yang, SH Chan, KS Cheng, SM Huang, IJ Su
Human Pathology 1997
Disulfide Structure of the Heparin Binding Domain in Vascular Endothelial Growth Factor: Characterization of Posttranslational Modifications in VEGF
RG Keck, L Berleau, R Harris, BA Keyt
Archives of Biochemistry and Biophysics 1997
Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies
S Takeshita, LP Zheng, E Brogi, M Kearney, LQ Pu, S Bunting, N Ferrara, JF Symes, JM Isner
Journal of Clinical Investigation 1997
The Biology of Vascular Endothelial Growth Factor
N Ferrara, T Davis-Smyth
Endocrine reviews 1997
Molecular analysis of blood vessel formation and disease
N Ferrara
The American journal of physiology 1997
Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies
S Takeshita, LP Zheng, E Brogi, M Kearney, LQ Pu, S Bunting, N Ferrara, JF Symes, JM Isner
Journal of Clinical Investigation 1997
VEGF 145 , a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix
Z Poltorak, T Cohen, R Sivan, Y Kandelis, G Spira, I Vlodavsky, E Keshet, G Neufeld
The Journal of biological chemistry 1997
A High Pretreatment Serum Vascular Endothelial Growth Factor Concentration Is Associated With Poor Outcome in Non-Hodgkin's Lymphoma
P Salven, L Teerenhovi, H Joensuu
Blood 1997
Review
M Epstein
Renal Failure 1996
Arterial Gene Transfer for Therapeutic Angiogenesis in Patients with Peripheral Artery Disease. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts
JM Isner, K Walsh, J Symes, A Pieczek, S Takeshita, J Lowry, K Rosenfield, L Weir, E Brogi, D Jurayj
Human Gene Therapy 1996
Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
K Anan, T Morisaki, M Katano, A Ikubo, H Kitsuki, A Uchiyama, S Kuroki, M Tanaka, M Torisu
Surgery 1996
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
SY Cheng, HJ Huang, M Nagane, XD Ji, D Wang, CC Shih, W Arap, CM Huang, WK Cavenee
Proceedings of the National Academy of Sciences 1996
Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis
CG Kevil, AD Benedetti, DK Payne, LL Coe, FS Laroux, JS Alexander
International Journal of Cancer 1996
The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin
S Staibano, A Boscaino, G Salvatore, P Orabona, L Palombini, GD Rosa
Human Pathology 1996
Arterial gene therapy
H Schneider, K Huse
The Lancet 1996
The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency
BA Keyt, LT Berleau, HV Nguyen, H Chen, H Heinsohn, R Vandlen, N Ferrara
The Journal of biological chemistry 1996
Selective Binding of VEGF to One of the Three Vascular Endothelial Growth Factor Receptors of Vascular Endothelial Cells
H Gitay-Goren, T Cohen, S Tessler, S Soker, S Gengrinovitch, P Rockwell, M Klagsbrun, BZ Levi, G Neufeld
The Journal of biological chemistry 1996
Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent
KA Thomas
The Journal of biological chemistry 1996
Regulation of Angiogenesis
ID Goldberg, EM Rosen
1996
Molecular, Cellular, and Clinical Aspects of Angiogenesis
ME Maragoudakis
1996
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
G Neufeld, T Cohen, H Gitay-Goren, Z Poltorak, S Tessler, R Sharon, S Gengrinovitch, BZ Levi
Cancer and Metastasis Reviews 1996
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
RS Warren, H Yuan, MR Matli, NA Gillett, N Ferrara
Journal of Clinical Investigation 1995
Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures
A Ijichi, S Sakuma, PJ Tofilon
Glia 1995
The Regulation of Blood Vessel Growth by Vascular Endothelial Growth Factor
N Ferrara, H Heinsohn, CE Walder, S Bunting, GR Thomas
Annals of the New York Academy of Sciences 1995
Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice
AJ Pötgens, NH Lubsen, MC van Altena, JG Schoenmakers, DJ Ruiter, RM de Waal
The American Journal of Pathology 1995
Significance of tumor-host interactions in cancer growth and metastases
RS Kerbel
Cancer and Metastasis Reviews 1995
Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF
JC Tsai, CK Goldman, GY Gillespie
Journal of Neurosurgery 1995
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
A Tufró
Journal of cell science 1995
VEGF mRNA is Reversibly Stabilized by Hypoxia and Persistently Stabilized in VEGF-Overexpressing Human Tumor Cell Lines
FC White, SM Carroll, MP Kamps
Growth Factors 1995
Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF 121 and VEGF 165 Using Several Concurrent Mechanisms
S Gengrinovitch, SM Greenberg, T Cohen, H Gitay-Goren, P Rockwell, TE Maione, BZ Levi, G Neufeld
The Journal of biological chemistry 1995
Cardiovascular Disease 2
LL Gallo
1995
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
W Kolch, G Martiny-Baron, A Kieser, D Marm
Breast Cancer Research and Treatment 1995
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice
Y Zhang, Y Deng, T Luther, M Müller, R Ziegler, R Waldherr, DM Stern, PP Nawroth
Journal of Clinical Investigation 1994
Tumor invasion, proteolysis, and angiogenesis
UP Thorgeirsson, CK Lindsay, DW Cottam, DE Gomez
Journal of Neuro-Oncology 1994
Vascular targeting—a new approach to the therapy of solid tumors
FJ Burrows, PE Thorpe
Pharmacology & Therapeutics 1994
Transfected MCF-7 cells as a model for breast cancer progression
FG Kern, SW McLeskey, L Zhang, J Kurebayashi, Y Liu, IY Ding, S Kharbanda, D Chen, D Miller, K Cullen, S Paik, RB Dickson
Breast Cancer Research and Treatment 1994
Growth Factors and Wound Healing
HH Steenfos
Journal of Plastic and Reconstructive Surgery and Hand Surgery 1994
Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts
T Sugihara, SC Kaul, Y Mitsui, R Wadhwa
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1994
Brain Tumor Invasiveness
RH Goldfarb
1994
Vascular targeting and the inhibition of angiogenesis
R Bicknell
Annals of Oncology 1994
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors
S Tessler, P Rockwell, D Hicklin, T Cohen, BZ Levi, L Witte, IR Lemischka, G Neufeld
The Journal of biological chemistry 1994
Vascular endothelial growth factor
N Ferrara
Trends in Cardiovascular Medicine 1993
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
KJ Kim, B Li, J Winer, M Armanini, N Gillett, HS Phillips, N Ferrara
Nature 1993
Vascular permeability factor (VPF, VEGF) in tumor biology
DR Senger, LV Water, LF Brown, JA Nagy, KT Yeo, TK Yeo, B Berse, RW Jackman, AM Dvorak, HF Dvorak
Cancer and Metastasis Reviews 1993

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 7 patents
26 readers on Mendeley
See more details